Vertaling van "anxiety in patients with cancer " (Frans → Nederlands) :

DOI: 10.1002/14651858.CD004596. Traeger L, Greer JA, Fernandez-Robles C et al. Evidence-based treatment of anxiety in patients with cancer.
Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer.

Pilot clinical trial of antitumor vaccine with dendritic cells pulsed with multiple HLA-A2 and DP4 peptides and low doses cyclophosphamide to control regulatory T cells, in patients with metastatic lung cancer
Phase I/II study of a re-engineered autologous dendritic cell adjuvant vaccine in resectable non-small cell lung cancer

In line with the finding of more preoperative FNAC in the Flemish and the Brussels-Capital Region, the proportion of surgical patients with only a postoperative diagnosis of thyroid carcinoma (without prior FNAC) suggestive for an increased probability of undiagnosed and/or occult cancer finding was twice higher in the Walloon Region as compared to the Brussels-Capital and the Flemish Region.
postoperative diagnosis of thyroid carcinoma (without prior FNAC) suggestive for an increased probability of undiagnosed and/or occult cancer finding was twice higher in the Walloon Region as compared to the Brussels-Capital and the Flemish Region.

in 2008, with large variations between types of cancer (in 2008: 84% of breast cancer patients, 74% lung cancer, 59% prostate cancer).
Overall, about 69% of cancer patients were discussed at the MOC – COM in 2008, with large variations between types of cancer (in 2008: 84% of breast cancer patients, 74% lung cancer, 59% prostate cancer).

Notre devise est donc " targeting cancer with care" : c.-à-d. combattre le cancer d’une façon ciblée et spécifique tout en respectant et en maintenant la qualité de vie des patients.
Ons motto is dan ook “targeting cancer with care”: op een doelgerichte en specifieke manier de kanker bestrijden met respect voor en behoud van de levenskwaliteit van de individuele patiënt.

Treatment of patients with EGFRexpressing metastatic colorectal cancer in combination with irinotecan after failure of irinotecancontaining therapy
Treatment of patients with EGFRexpressing metastatic colorectal cancer in combination with irinotecan after failure of irinotecancontaining therapy

Alice T. Shaw, David G. Forcione, Subba R. Digumarthy, A. John Iafrate: Case 21-2011: A 31-Year-Old Man with ALK-Positive Adenocarcinoma of the Lung, New England Journal of Medicine, 2011; 365-2; 2-11 Étude de cas sur le traitement par un agent personnalisé d'un patient atteint d'un cancer du poumon
Alice T. Shaw, David G. Forcione, Subba R. Digumarthy, A. John Iafrate: Case 21-2011: A 31-Year-Old Man with ALK-Positive Adenocarcinoma of the Lung, New England Journal of Medicine, 2011; 365-2; 2-11 Een casestudy over de behandeling van een patiënt met longkanker met behulp van een gepersonaliseerde werkzame stof.

42. Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid Cancer in Patients with Hyperthyroidism.
41. Berker D, Isik S, Ozuguz U, et al. Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism.

41. Berker D, Isik S, Ozuguz U, et al. Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism.
Carlé A, Pedersen IB, Knudsen N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study.

perception in patients with advanced cancer.
dyspnea perception in patients with advanced cancer.